Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Oratecan
Locations
2
United States
University of Colorado Cancer Center
Aurora, Colorado, United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Start Date
September 5, 2014
Primary Completion Date
March 4, 2020
Completion Date
March 4, 2020
Last Updated
February 22, 2022
NCT05720117
NCT06898450
NCT06658951
NCT06625775
NCT05101070
NCT05098132
Lead Sponsor
Athenex, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions